- [Alt + 0] - Startseite
- [Alt + 1] - Navigation
- [Alt + 2] - Inhalt
- [Alt + 3] - Contact
- [Alt + 4] - Sitemap
- [Alt + 5] - Search
EN: Navigation mit Access Keys
Newsroom
26.11.2018
Octapharma receives Swissmedic approval for fibryga® to treat congenital and acquired fibrinogen deficiencies
Lachen, Switzerland – 26 November 2018 – Octapharma today announced that the Swiss Agency for Therap...
21.09.2018
Octapharma to invest Euro 21 million to build a new multi-use venue in Springe, Germany
Octapharma has confirmed to invest Euro 21 million to build a new multi-function facility in Sprin...